China News Service, Shanghai, February 17 (Reporter Chen Jing) Various anti-tumor treatments may cause myocardial damage to varying degrees, which has become the consensus of experts at home and abroad.
The reporter learned on the 17th that the tumor and heart disease team of Zhongshan Hospital affiliated to Fudan University sought answers from the treasure house of traditional medicine of the motherland.
They found that, as an effective drug for the treatment of ischemic cardiomyopathy, total crocin not only improves myocardial oxygen supply, but also has a good therapeutic effect on mild immune myocarditis caused by the treatment of related anticancer drugs.
The relevant basic research results were published in the well-known international journal "Journal of inflammation research".
In the "Science and Technology Meeting Room" activity of the Shanghai Science Hall held on the same day, the "Clinical Trial of Total Crocin in the Treatment of Mild Immune Myocarditis" was officially launched on the same day.
It is reported that total saffron glucosides, also known as crocin and crocin, have antioxidant, anti-hypertensive, atherosclerotic and other effects, and can also improve the partial pressure of oxygen in mammalian blood.
It is reported that clinically, "getting a tumor, but dying of the heart" really occurs in many patients with malignant tumors.
The tumor cardiology team told reporters that while PD1 inhibitors and other immune checkpoint inhibitors are used as "anti-cancer magic drugs", they may cause extremely dangerous immune myocarditis. The mortality rate of severe patients is nearly 50%, and there are a large number of Mild patients are in a dilemma between tumor treatment and protection of the heart.
The "Science and Technology Meeting Room" activity of Shanghai Science Hall was held.
Photo courtesy of Zhongshan Hospital
As an academician of the Chinese Academy of Sciences and director of the Department of Cardiology of Zhongshan Hospital Affiliated to Fudan University, Ge Junbo told reporters that in April 2018, Zhongshan Hospital took the lead in opening a multidisciplinary joint outpatient clinic for oncology cardiology in East China; It opened a new window for cancer patients with cardiovascular disease.
Over the years, the Fudan Zhongshan Oncology Cardiology Team has solved problems for thousands of patients with tumors complicated by cardiovascular diseases and provided cutting-edge medical guidance.
Today, oncological cardiology has become a new interdisciplinary subject. The oncological cardiology team rewrites real clinical cases into medical science storybooks, shoots micro-movies, and uses various forms of popular science to "run and tell each other". It is hoped that medical staff and patients will We can discover this field and make joint efforts to improve the quality of life of cancer patients.
In this regard, Ma Xingfa, Secretary of the Party Group of the Shanghai Association for Science and Technology, advocated the cooperation of medical experts, entrepreneurs, scientific and technological workers and the media to push the popularization work to a new level.
Wang Tong, director of the Health Promotion Division of the Shanghai Municipal Health and Health Commission, hoped that medical institutions at all levels and the majority of medical workers will give full play to their advantages, strengthen doctor-patient communication and popular science publicity, and accurately meet the health needs of the public.
On the same day, "Speak Your Heart 3" written by Chief Physician Cheng Leilei, the leader of the "Oncology Cardiology" team of Zhongshan Hospital, was released at the event.
The book integrates the obscure and difficult medical knowledge points into the human world with plain language and delicate brushstrokes; at the same time, it explains how to make early diagnosis, early prevention and scientific medical treatment of cardiovascular diseases.
The stories in the book are selected from more than 10,000 clinical cases handled by Cheng Leilei in the past 20 years, especially focusing on the popular knowledge of oncology and cardiology that the public knows little about, such as how patients with malignant tumors are treated with immune checkpoint inhibitors. Perform cardiac self-monitoring, how to seek medical attention if breast cancer patients develop heart problems, and more.
The tumor heart disease micro-movie "Speak Your Heart" was also announced at the event.
(Finish)